FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2154686056> ?p ?o ?g. }

• W2154686056 endingPage "144" @default.
• W2154686056 startingPage "133" @default.
• W2154686056 abstract "Twenty-nine cats with naturally occurring cryptococcosis were evaluated prior to commencing oral fluconazole therapy (25-100 mg every 12 h). Affected cats ranged from 2 to 15 years-of-age. Male cats (19; 66%) and Siamese cats (5; 21%) appeared to be over-represented in comparison to the hospital's cat population. Mycotic rhinitis was observed in 24 (83%) of the cases, although nasal cavity involvement was subtle in four animals. Disease of the skin and subcutaneous tissues was present in 15 cases (52%) and amongst these the nasal plane (seven cats) and bridge of the nose (seven cats) were most commonly involved. Primary infection of the central nervous system was not encountered, although one cat developed meningoencephalitis and optic neuritis as a sequel to longstanding nasal cavity disease. Antibodies against the feline immunodeficiency virus (FIV) were detected in eight cats (28%), and these cats tended to have advanced and/or disseminated disease. There was a tendency for cats to develop cryptococcosis during the Australian summer. Organisms were cultured from 27 cases. Cryptococcus neoformans var. neoformans was isolated from 21 cats, while C. neoformans var. gattii was identified in the remaining six. The response to oral fluconazole was excellent in this series, which included many cats with advanced, longstanding or disseminated disease. The fungal infection resolved in all but one advanced case which died after only 4 days of therapy. A dose of 50 mg per cat, given every 12 h, produced a consistently good response without side effects. Lower doses were effective in some cases, while 100 mg every 12 h was required to control the infection in one cat. Serum fluconazole levels obtained during chronic dosing (50 +/- 18 mg l-1, mean +/- SD; 50 mg per cat every 12 h) were highly variable (range 15-80 mg l-1). Concurrent FIV infection did not impart an unfavourable prognosis, although affected cats often required prolonged courses of therapy." @default.
• W2154686056 created "2016-06-24" @default.
• W2154686056 creator A5053202310 @default.
• W2154686056 creator A5054885182 @default.
• W2154686056 creator A5059001810 @default.
• W2154686056 creator A5068349441 @default.
• W2154686056 creator A5076742447 @default.
• W2154686056 date "1992-01-01" @default.
• W2154686056 modified "2023-10-01" @default.
• W2154686056 title "Cryptococcosis in cats: clinical and mycological assessment of 29 cases and evaluation of treatment using orally administered fluconazole" @default.
• W2154686056 cites W1547649925 @default.
• W2154686056 cites W1594591013 @default.
• W2154686056 cites W1967998262 @default.
• W2154686056 cites W1968026345 @default.
• W2154686056 cites W1971920484 @default.
• W2154686056 cites W1987504274 @default.
• W2154686056 cites W1991387601 @default.
• W2154686056 cites W1995431528 @default.
• W2154686056 cites W2017253392 @default.
• W2154686056 cites W2017384542 @default.
• W2154686056 cites W2027414134 @default.
• W2154686056 cites W2067468223 @default.
• W2154686056 cites W2070344812 @default.
• W2154686056 cites W2105272521 @default.
• W2154686056 cites W2138034680 @default.
• W2154686056 cites W2155736284 @default.
• W2154686056 cites W2160251188 @default.
• W2154686056 cites W3022709789 @default.
• W2154686056 cites W4292766409 @default.
• W2154686056 doi "https://doi.org/10.1080/02681219280000181" @default.
• W2154686056 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1588463" @default.
• W2154686056 hasPublicationYear "1992" @default.
• W2154686056 type Work @default.
• W2154686056 sameAs 2154686056 @default.
• W2154686056 citedByCount "168" @default.
• W2154686056 countsByYear W21546860562012 @default.
• W2154686056 countsByYear W21546860562013 @default.
• W2154686056 countsByYear W21546860562014 @default.
• W2154686056 countsByYear W21546860562015 @default.
• W2154686056 countsByYear W21546860562016 @default.
• W2154686056 countsByYear W21546860562017 @default.
• W2154686056 countsByYear W21546860562018 @default.
• W2154686056 countsByYear W21546860562019 @default.
• W2154686056 countsByYear W21546860562020 @default.
• W2154686056 countsByYear W21546860562021 @default.
• W2154686056 countsByYear W21546860562022 @default.
• W2154686056 countsByYear W21546860562023 @default.
• W2154686056 crossrefType "journal-article" @default.
• W2154686056 hasAuthorship W2154686056A5053202310 @default.
• W2154686056 hasAuthorship W2154686056A5054885182 @default.
• W2154686056 hasAuthorship W2154686056A5059001810 @default.
• W2154686056 hasAuthorship W2154686056A5068349441 @default.
• W2154686056 hasAuthorship W2154686056A5076742447 @default.
• W2154686056 hasConcept C126322002 @default.
• W2154686056 hasConcept C141071460 @default.
• W2154686056 hasConcept C142724271 @default.
• W2154686056 hasConcept C16005928 @default.
• W2154686056 hasConcept C203014093 @default.
• W2154686056 hasConcept C2522874641 @default.
• W2154686056 hasConcept C2777841672 @default.
• W2154686056 hasConcept C2777893358 @default.
• W2154686056 hasConcept C2778311950 @default.
• W2154686056 hasConcept C2778621254 @default.
• W2154686056 hasConcept C2779413141 @default.
• W2154686056 hasConcept C2779548794 @default.
• W2154686056 hasConcept C2779690655 @default.
• W2154686056 hasConcept C2779904517 @default.
• W2154686056 hasConcept C2780651595 @default.
• W2154686056 hasConcept C2780727368 @default.
• W2154686056 hasConcept C71924100 @default.
• W2154686056 hasConcept C86803240 @default.
• W2154686056 hasConcept C89423630 @default.
• W2154686056 hasConceptScore W2154686056C126322002 @default.
• W2154686056 hasConceptScore W2154686056C141071460 @default.
• W2154686056 hasConceptScore W2154686056C142724271 @default.
• W2154686056 hasConceptScore W2154686056C16005928 @default.
• W2154686056 hasConceptScore W2154686056C203014093 @default.
• W2154686056 hasConceptScore W2154686056C2522874641 @default.
• W2154686056 hasConceptScore W2154686056C2777841672 @default.
• W2154686056 hasConceptScore W2154686056C2777893358 @default.
• W2154686056 hasConceptScore W2154686056C2778311950 @default.
• W2154686056 hasConceptScore W2154686056C2778621254 @default.
• W2154686056 hasConceptScore W2154686056C2779413141 @default.
• W2154686056 hasConceptScore W2154686056C2779548794 @default.
• W2154686056 hasConceptScore W2154686056C2779690655 @default.
• W2154686056 hasConceptScore W2154686056C2779904517 @default.
• W2154686056 hasConceptScore W2154686056C2780651595 @default.
• W2154686056 hasConceptScore W2154686056C2780727368 @default.
• W2154686056 hasConceptScore W2154686056C71924100 @default.
• W2154686056 hasConceptScore W2154686056C86803240 @default.
• W2154686056 hasConceptScore W2154686056C89423630 @default.
• W2154686056 hasIssue "2" @default.
• W2154686056 hasLocation W21546860561 @default.
• W2154686056 hasLocation W21546860562 @default.
• W2154686056 hasOpenAccess W2154686056 @default.
• W2154686056 hasPrimaryLocation W21546860561 @default.
• W2154686056 hasRelatedWork W1968089563 @default.
• W2154686056 hasRelatedWork W2021884884 @default.

• next